BI 409306 Cardiac Safety Trial in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 4, 2015

Primary Completion Date

August 12, 2015

Study Completion Date

August 13, 2015

Conditions
Healthy
Interventions
DRUG

BI 409306

high dose, single dose, oral administration

DRUG

BI 409306

low dose, single dose, oral administration

DRUG

Placebo

single dose, oral administration

Trial Locations (1)

Unknown

1289.28.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY